Literature DB >> 28727907

Novel role of surfactant protein A in bacterial sinusitis.

George T Noutsios1, Amanda L Willis1, Julie G Ledford2, Eugene H Chang1.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a common inflammatory disorder of the upper airway characterized by chronic inflammation and significant sinonasal remodeling. CRS is comprised of 2 major subgroups, based on whether polyps are present or absent. In some cases, it is characterized by colonization with opportunistic pathogens such as Pseudomonas aeruginosa (PA), Staphylococcus aureus, and other bacteria. The innate immune system of the sinonasal epithelium is the first line of defense against inhaled pathogens. Surfactant protein A (SP-A) is a member of the collectin family secreted by the airway epithelia and plays a critical role in airway innate immunity, as it can aggregate bacteria. We hypothesized that SP-A plays a role in bacterial CRS.
METHODS: Air-liquid interface (ALI) cultures of nasal epithelial cells were derived from human ex-vivo healthy and CRS sinus tissues (n = 26) and challenged with PA. SP-A levels were measured with western blot and quantitative reverse transcript-polymerase chain reaction (qRT-PCR) in ALI and sinus tissues.
RESULTS: We determined that SP-A: (i) mRNA and protein levels are increased significantly in CRS tissues compared with healthy sinuses; (ii) although primarily expressed in the lung, it is also synthesized and expressed in sinonasal epithelia; (ii) is expressed in the sinuses of an SP-A humanized transgenic mouse but not in SP-A knockout mice; (iv) mRNA levels are upregulated significantly during PA challenge, but protein levels are downregulated 4 hours postchallenge and upregulated at 12 hours.
CONCLUSION: Our data suggest that SP-A is expressed in the sinuses and that it plays a role in the sinus innate immune responses during bacterial infections.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  CRS; innate immunity, Pseudomonas aeruginosa, rhinosinusitis, SP-A

Mesh:

Substances:

Year:  2017        PMID: 28727907      PMCID: PMC5783157          DOI: 10.1002/alr.21985

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  27 in total

1.  Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.

Authors:  Anatoly N Mikerov; Guirong Wang; Todd M Umstead; Mario Zacharatos; Neal J Thomas; David S Phelps; Joanna Floros
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

2.  Association between the CDHR3 rs6967330 risk allele and chronic rhinosinusitis.

Authors:  Eugene H Chang; Amanda L Willis; Hilary C McCrary; George T Noutsios; Christopher H Le; Alexander G Chiu; Corrine J Mansfield; Danielle R Reed; Steven G Brooks; Nithin D Adappa; James N Palmer; Noam G Cohen; Debra A Stern; Stefano Guerra; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2016-12-03       Impact factor: 10.793

3.  Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

Authors:  A M LeVine; J A Whitsett; K L Hartshorn; E C Crouch; T R Korfhagen
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

4.  Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

Authors:  A M LeVine; J Gwozdz; J Stark; M Bruno; J Whitsett; T Korfhagen
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 5.  Surfactant regulation of host defense function in the lung: a question of balance.

Authors:  D S Phelps
Journal:  Pediatr Pathol Mol Med       Date:  2001 Jul-Aug

6.  EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

Authors:  Wytske J Fokkens; Valerie J Lund; Joachim Mullol; Claus Bachert; Isam Alobid; Fuad Baroody; Noam Cohen; Anders Cervin; Richard Douglas; Philippe Gevaert; Christos Georgalas; Herman Goossens; Richard Harvey; Peter Hellings; Claire Hopkins; Nick Jones; Guy Joos; Livije Kalogjera; Bob Kern; Marek Kowalski; David Price; Herbert Riechelmann; Rodney Schlosser; Brent Senior; Mike Thomas; Elina Toskala; Richard Voegels; De Yun Wang; Peter John Wormald
Journal:  Rhinology       Date:  2012-03       Impact factor: 3.681

7.  Pseudomonas aeruginosa degrades pulmonary surfactant and increases conversion in vitro.

Authors:  Alexis L Beatty; Jaret L Malloy; Jo Rae Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2004-11-04       Impact factor: 6.914

8.  Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice.

Authors:  Rizwanul Haque; Todd M Umstead; Padmavathi Ponnuru; Xiaoxuan Guo; Samuel Hawgood; David S Phelps; Joanna Floros
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-23       Impact factor: 4.219

9.  The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms.

Authors:  Anne Jäkel; Howard Clark; Kenneth B M Reid; Robert B Sim
Journal:  Immunobiology       Date:  2009-10-31       Impact factor: 3.144

10.  Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.

Authors:  Kosuke Kato; Erik P Lillehoj; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2015-12-08       Impact factor: 4.575

View more
  1 in total

1.  The alveolar macrophage toponome of female SP-A knockout mice differs from that of males before and after SP-A1 rescue.

Authors:  David S Phelps; Vernon M Chinchilli; Lili Yang; Debra Shearer; Judith Weisz; Xuesheng Zhang; Joanna Floros
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.